The global demand for Autotransfusion Devices Market is presumed to reach the valuation of nearly USD XXX MN by 2026 from USD XXX MN in 2019 with a CAGR of X.XX% under the study period of 2020 - 2026. Whereas with regards to volume, the market was calculated XXX Kilo Units in 2019 and foreseen to touch XXX Kilo Units by 2026 with a CAGR of X.X% during 2020-2026.
Autotransfusion device is a sophisticated system with an effective design that provides autologous blood during surgical procedures. These are used by clinicians and surgical teams concerned with blood conservation. The device play an integral role for certain patient populations refusing transfusion for reasons of faith or otherwise. The technique reduces the need for allogeneic blood transfusion. Autotransfusion devices are intended for use in situations characterized by the loss of one or more units of blood and maybe particularly advantageous for use in cases involving risk of infectious disease transmission, rare blood groups, restricted homologous blood supply, or other medical situations for which the use of homologous blood is contraindicated.
Growing blood transfusion reaction cases and growing incidence of postoperative complications and other potential hazards of blood transfusion prompted a review of transfusion practices and a search for blood conservation measures. Autotransfusion techniques reduce the need for allogeneic blood transfusion. Patients are transfused with their own blood through either preoperative self-donation or intraoperative blood salvage. It is a safe, reliable and cost-effective method. Blood transfusions have been associated with higher rates of mortality and morbidity, increased hospital-acquired infections, length of stay, readmissions, and other complications. Research revealed that up to 60% of transfusions are either inappropriate or not demonstrably effective. This has given boost to autotransfusion practices. However, a high cost of autotransfusion systems and risks associated with autotransfusion is hindering the growth of market.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of Autotransfusion Devices.
The entire Autotransfusion Devices market has been sub-categorized into product, application, and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
- Autotransfusion Systems
- Consumables & Accessories
By End User
- Cardiovascular Surgeries
- Orthopedic Surgeries
- Neurological Surgeries
- Obstetrics & Gynecological Surgeries
- Specialty Clinics & Others
This section covers regional segmentation which accentuates on current and future demand for Autotransfusion Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Europe Autotransfusion Devices Market By Revenue (USD MN)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Autotransfusion Devices market include Haemonetics Corporation, LivaNova PLC, Medtronic, Fresenius SE & Co. KgaA, BD. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.